Autres avocats qui pourraient vous intéresser
Andrew Payne
Andrew is a senior associate in the intellectual property team and provides advice on contentious and non-contentious patent issues. He has a particular interest in advising life sciences companies, following a previous career as a medicinal chemist in the pharmaceutical industry.
Afficher le CV complet
Masquer le CV complet
Voir plus
Moins
Voir plus
Moins
Carrière
| Since 2020 | Senior Associate, Taylor Wessing |
| 2015 - 2020 | Associate, Taylor Wessing |
| 2013 - 2015 | Trainee Solicitor , CMS Cameron McKenna |
| 2009 - 2013 | Group Leader, Medicinal Chemistry at Eisai |
| 2000 - 2009 | Team Leader, GlaxoSmithKline |
| 1998 - 1999 | Postdoctoral Researcher, The University of Texas at Austin |
Formation
| 2015 | Admitted as a lawyer, England & Wales |
| 2013 | LPC distinction, BPP Law School |
| 2011 | GDL commendation, BPP Law School, London |
| 1997 | PhD in synthetic organic chemistry from Imperial College, London |
| 1994 | BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy |
Publications
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128 |
Langues étrangères
| English |
Actualités et publications récentes
Sciences de la vie et Santé
Cliquer ici pour en savoir plus
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
30 mars 2018
Briefing
par Andrew Payne
Sciences de la vie et Santé
Cliquer ici pour en savoir plus
Licence held to be exclusive despite option
28 février 2018
Briefing
par Andrew Payne
Synapse
Cliquer ici pour en savoir plus
Data exclusivity for innovators - a bridge too far?
1 septembre 2016
QUICK READ
par Andrew Payne
Sciences de la vie et Santé
Cliquer ici pour en savoir plus
High Court grants declaratory relief in pharmaceutical regulatory dispute
2 janvier 2016
Briefing
par Andrew Payne
